User profiles for N Kanu
Nand Jee Kanu, PhDAssistant Professor, Mechanical, JSPM NTC, Pune, India Verified email at med.svnit.ac.in Cited by 856 |
[HTML][HTML] Perspective: APOBEC mutagenesis in drug resistance and immune escape in HIV and cancer evolution
The apolipoprotein B mRNA-editing enzyme, catalytic polypeptide-like (APOBEC)
mutational signature has only recently been detected in a multitude of cancers through next-…
mutational signature has only recently been detected in a multitude of cancers through next-…
[HTML][HTML] A comprehensive survey of the mutagenic impact of common cancer cytotoxics
B Szikriszt, Á Póti, O Pipek, M Krzystanek, N Kanu… - Genome biology, 2016 - Springer
Background Genomic mutations caused by cytotoxic agents used in cancer chemotherapy
may cause secondary malignancies as well as contribute to the evolution of treatment-…
may cause secondary malignancies as well as contribute to the evolution of treatment-…
[HTML][HTML] Self-healing composites: A state-of-the-art review
… - 1 / V ∫ d c w A c field φ A r + w B c field φ B c where Q d , p a r t i t i o n is partition … n t r o
p i c = ϕ P α ln Q partition α V ϕ P - 1 / V ∫ d c w p c ρ p c particle c e n t r e - ρ p c particle c e n …
p i c = ϕ P α ln Q partition α V ϕ P - 1 / V ∫ d c w p c ρ p c particle c e n t r e - ρ p c particle c e n …
[HTML][HTML] Insertion-and-deletion-derived tumour-specific neoantigens and the immunogenic phenotype: a pan-cancer analysis
… We assessed in-silico tumour-specific neoantigen predictions by mutation type with pan-cancer
analysis, together with RNAseq profiling in renal clear cell carcinoma cases (n=392), to …
analysis, together with RNAseq profiling in renal clear cell carcinoma cases (n=392), to …
Replication stress links structural and numerical cancer chromosomal instability
… i, Distribution of replication fork rates (CldU, n > 300 forks in total per cell line, n = 3 experiments),
with mean replication fork rates (CldU, n > 60 forks per experiment, mean ± sem, n = 3 …
with mean replication fork rates (CldU, n > 60 forks per experiment, mean ± sem, n = 3 …
Lung adenocarcinoma promotion by air pollutants
…, C Abbosh, N Kanu, SH Lee, N McGranahan… - Nature, 2023 - nature.com
… per mm 2 of lung tissue (n = 16 for the PBS and 5 μg PM groups, n = 15 for the 50 μg PM
group). … to PM or PBS over time (n = 5 for 3 week control and 50 μg PM; n = 6, 10 week control; …
group). … to PM or PBS over time (n = 5 for 3 week control and 50 μg PM; n = 6, 10 week control; …
[HTML][HTML] Pandemic peak SARS-CoV-2 infection and seroconversion rates in London frontline health-care workers
…, L Jenkins, M Jiang, M Johnson, L Jones, N Kanu… - The Lancet, 2020 - thelancet.com
To evaluate these risks, we enrolled 200 patient-facing HCWs between March 26 and April 8,
2020, in SARS-CoV-2 Acquisition in Frontline Healthcare Workers—Evaluation to inform …
2020, in SARS-CoV-2 Acquisition in Frontline Healthcare Workers—Evaluation to inform …
[PDF][PDF] Determinants of anti-PD-1 response and resistance in clear cell renal cell carcinoma
…, L Manzano, M Al-Bakir, S Summan, N Kanu… - Cancer cell, 2021 - cell.com
… The numbers (n) of patients contributing to sample collection at different timepoints are
shown. (B) Heatmap of WES analysis demonstrating nsSNV and INDEL burden, somatic driver …
shown. (B) Heatmap of WES analysis demonstrating nsSNV and INDEL burden, somatic driver …
Evolutionary characterization of lung adenocarcinoma morphology in TRACERx
…, H Zhai, F Gimeno-Valiente, S Saghafinia, N Kanu… - Nature medicine, 2023 - nature.com
… LNs (n = 83) and intrapulmonary metastasis (n = 2) removed at the time of primary surgery,
and sites of disease relapse sampled using diagnostic biopsies or surgical resection (n = 36). …
and sites of disease relapse sampled using diagnostic biopsies or surgical resection (n = 36). …
[HTML][HTML] Genomic–transcriptomic evolution in lung cancer and metastasis
… Displayed are the top PCs within LUADs (n = 480 regions from 190 tumours) and LUSCs (n
= … tumours with more than one sample at that time point (n = 845 regions from 283 tumours). …
= … tumours with more than one sample at that time point (n = 845 regions from 283 tumours). …